FITC-Labeled Human Siglec-2 / CD22 Protein, His Tag
分子別名(Synonym)
CD22,SIGLEC2,BL-CAM,SIGLEC-2,Siglec2,SIGLEC2FLJ22814
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
FITC-Labeled Human Siglec-2, His Tag (Cat. No. SI2-HF2H6) is expressed from human HEK293 cells. It contains AA Asp 20 - Arg 687 (Accession # P20273-1). It is the FITC labeled form of Human Siglec-2, His Tag (Cat. No. CD2-H52H8).
Predicted N-terminus: Asp 20
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 77.0 kDa. The protein migrates as 100-120 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
偶聯(lián)(Conjugate)
FITC
Excitation source: 488 nm spectral line, argon-ion laser
Excitation Wavelength: 488 nm
Emission Wavelength: 535 nm
標(biāo)記(Labeling)
The primary amines in the side chains of lysine residues and the N-terminus of the protein are conjugated with FITC using standard chemical labeling method. The residual FITC is removed by molecular sieve treatment during purification process.
蛋白標(biāo)記度(Protein Ratio)
The FITC to protein molar ratio is 3-5.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
B細(xì)胞受體CD22也被稱為唾液酸結(jié)合Ig樣凝集素2(Siglec-2)、B淋巴細(xì)胞粘附分子(BL-CAM)、T細(xì)胞表面抗原Leu-14,屬于免疫球蛋白超家族和Siglec(唾液酸結(jié)合Ig-like凝集素)家族。CD22介導(dǎo)B細(xì)胞與B細(xì)胞的相互作用,并可能參與B細(xì)胞在淋巴組織中的定位。Siglec-2/CD22結(jié)合唾液酸化糖蛋白,其中之一是CD45。Siglec2/CD22通過與Src家族酪氨酸激酶的相互作用在正向調(diào)節(jié)中發(fā)揮作用,也可能通過其SH2結(jié)構(gòu)域招募細(xì)胞質(zhì)磷酸酶來(lái)充當(dāng)抑制性受體,SH2結(jié)構(gòu)區(qū)通過信號(hào)分子的去磷酸化阻斷信號(hào)轉(zhuǎn)導(dǎo)。
關(guān)鍵字: Siglec-2;Siglec-2蛋白;Siglec-2重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。